These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14624636)

  • 1. Influence of targeting ligand flexibility on receptor binding of particulate drug delivery systems.
    Olivier V; Meisen I; Meckelein B; Hirst TR; Peter-Katalinic J; Schmidt MA; Frey A
    Bioconjug Chem; 2003; 14(6):1203-8. PubMed ID: 14624636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grafting protein ligand monolayers onto the surface of microparticles for probing the accessibility of cell surface receptors.
    Frey A; Meckelein B; Schmidt MA
    Bioconjug Chem; 1999; 10(4):562-71. PubMed ID: 10411452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding potential between the cholera toxin B-oligomer and its receptor.
    Cai XE; Yang J
    Biochemistry; 2003 Apr; 42(14):4028-34. PubMed ID: 12680755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands.
    Yao YC; Zhan XY; Zhang J; Zou XH; Wang ZH; Xiong YC; Chen J; Chen GQ
    Biomaterials; 2008 Dec; 29(36):4823-30. PubMed ID: 18824258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of pyrene-labeled monosialoganglioside GM1 micelles with cholera toxin.
    Picking WD
    Biochem Biophys Res Commun; 1993 Sep; 195(3):1153-8. PubMed ID: 8216243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanodiscs for immobilization of lipid bilayers and membrane receptors: kinetic analysis of cholera toxin binding to a glycolipid receptor.
    Borch J; Torta F; Sligar SG; Roepstorff P
    Anal Chem; 2008 Aug; 80(16):6245-52. PubMed ID: 18616345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting.
    Vyas SP; Singh A; Sihorkar V
    Crit Rev Ther Drug Carrier Syst; 2001; 18(1):1-76. PubMed ID: 11326743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity.
    Eniola AO; Hammer DA
    Biomaterials; 2005 Feb; 26(6):661-70. PubMed ID: 15282144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of multivalent ligands to mobile receptors in membranes.
    Dwyer JD; Bloomfield VA
    Biopolymers; 1981 Nov; 20(11):2323-36. PubMed ID: 6272898
    [No Abstract]   [Full Text] [Related]  

  • 10. Destruction of cholera toxin receptor on HeLa cell membrane using microbial endoglycoceramidase.
    Yamamoto K; Nagano T; Kumagai H; Okamoto Y; Otani S
    Arch Biochem Biophys; 1996 Apr; 328(1):51-6. PubMed ID: 8638937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting drugs to combinations of receptors: a modeling analysis of potential specificity.
    Caplan MR; Rosca EV
    Ann Biomed Eng; 2005 Aug; 33(8):1113-24. PubMed ID: 16133919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand based dendritic systems for tumor targeting.
    Agarwal A; Saraf S; Asthana A; Gupta U; Gajbhiye V; Jain NK
    Int J Pharm; 2008 Feb; 350(1-2):3-13. PubMed ID: 18162345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of linker length and flexibility on multivalent targeting.
    Shewmake TA; Solis FJ; Gillies RJ; Caplan MR
    Biomacromolecules; 2008 Nov; 9(11):3057-64. PubMed ID: 18828631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate chain of ganglioside GM1 as a ligand: identification of the binding strategies of three 15 mer peptides and their divergence from the binding modes of growth-regulatory galectin-1 and cholera toxin.
    Siebert HC; Born K; André S; Frank M; Kaltner H; von der Lieth CW; Heck AJ; Jiménez-Barbero J; Kopitz J; Gabius HJ
    Chemistry; 2005 Dec; 12(2):388-402. PubMed ID: 16267866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
    Campos SK; Barry MA
    Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
    Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization.
    Popielarski SR; Pun SH; Davis ME
    Bioconjug Chem; 2005; 16(5):1063-70. PubMed ID: 16173781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannose-based molecular patterns on stealth microspheres for receptor-specific targeting of human antigen-presenting cells.
    Wattendorf U; Coullerez G; Vörös J; Textor M; Merkle HP
    Langmuir; 2008 Oct; 24(20):11790-802. PubMed ID: 18785716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell targeting by a generic receptor-targeted polymer nanocontainer platform.
    Broz P; Benito SM; Saw C; Burger P; Heider H; Pfisterer M; Marsch S; Meier W; Hunziker P
    J Control Release; 2005 Feb; 102(2):475-88. PubMed ID: 15653165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.